Search

Gorazd Drozina Phones & Addresses

  • Silver Spring, MD
  • 415 Warren Dr APT 8, San Francisco, CA 94131
  • 1618 35Th Ave, San Francisco, CA 94122 (415) 665-4799
  • 643 2Nd Ave, San Francisco, CA 94118

Work

Company: Merck May 2013 Address: Palo Alto, CA Position: Associate director

Education

Degree: PhD in Medical sciences School / High School: Univerza v Ljubljani 2002 to 2007 Specialities: Molecular biology, Immunology

Languages

English • Slovenian

Awards

Preseren's award for Medical students at... • Soros Foundation scholarships in 1995, 1... • Zois scholarship for perspective student...

Interests

clinical research, medical writing

Industries

Biotechnology

Resumes

Resumes

Gorazd Drozina Photo 1

Associate Director At Merck

View page
Position:
Associate Director at Merck
Location:
San Francisco, California
Industry:
Biotechnology
Work:
Merck - Palo Alto, CA since May 2013
Associate Director

MedImmune Jul 2010 - May 2013
Manager, Science Submission Management

MedImmune Jun 2009 - Jul 2010
Scientific Writer

Roche Pharmaceuticals Aug 2008 - Jun 2009
Medical Writer

University Medical Center in Ljubljana, Slovenia May 2006 - Jun 2009
Clinical Researcher/Medical Writer
Education:
Univerza v Ljubljani 2002 - 2007
PhD in Medical sciences, Molecular biology, Immunology
Univerza v Ljubljani 1989 - 1999
MD, General medicine
Interests:
clinical research, medical writing
Honor & Awards:
Preseren's award for Medical students at the University of Ljubljana, 1997 Soros Foundation scholarships in 1995, 1996, 1997 Zois scholarship for perspective students awarded by Republic of Slovenia
Languages:
English
Slovenian

Publications

Us Patents

Expression Of Class Ii Transactivator Fusion Proteins For Control Of Tumor Growth

View page
US Patent:
20090047262, Feb 19, 2009
Filed:
Oct 30, 2007
Appl. No.:
11/981199
Inventors:
Gorazd Drozina - San Francisco CA, US
B. Matija Peterlin - San Francisco CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 35/12
C12N 15/11
C12N 15/00
A61P 31/00
C12N 5/06
US Classification:
424 9321, 536 234, 4353201, 435325
Abstract:
The present invention relates to tumor immunotherapy. In particular, the present invention provides methods and compositions for converting cancer cells into antigen presenting cells. Thus the present invention provides immunogenic compositions for the treatment and prevention of cancer.
Gorazd Drozina from Silver Spring, MD, age ~54 Get Report